S. Seiwerthet al., Stable Gastric Pentadecapeptide BPC 157 and Wound Healing, Frontiers Media SA, Jun. 2021. doi: 10.3389/fphar.2021.627533
26%* WEIGHT The Science Speaks for Itself EllieMD offers a powerful, pharmacologically-backed approach to metabolic health and sustainable weight management
Typical effective dosing: The dosing is specific to each patient based on weight, what the injection is being used for, and tolerance to the injection
Since then, several GLP-1s for obesity have been approved for new indications, such as secondary cardiovascular risk reduction (Wegovy), sleep apnea (Zepbound) and metabolic dysfunction-associated steatohepatitis, or MASH (Wegovy)
How can we think that manipulating our GLP or GIP production in such drastic ways would not have a downstream impact somewhere else
M., Aletras, A